Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol supplementation in Nonalcoholic Fatty Liver Disease
IRCT2017053034222N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of calcitriol in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
calcitriol
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT2017053034222N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017053034222N1.